AAAAAA

   
Results: 1-17 |
Results: 17

Authors: GRISWOLD MW BRICELAND LL STEIN DS
Citation: Mw. Griswold et al., IS AMPHOTERICIN-B TEST DOSING NEEDED, The Annals of pharmacotherapy, 32(4), 1998, pp. 475-477

Authors: HAMILTON RA BRICELAND LL ANDRITZ MH
Citation: Ra. Hamilton et al., FREQUENCY OF HOSPITALIZATION AFTER EXPOSURE TO KNOWN DRUG-DRUG INTERACTIONS IN A MEDICAID POPULATION, Pharmacotherapy, 18(5), 1998, pp. 1112-1120

Authors: BRICELAND LL HAMILTON RA
Citation: Ll. Briceland et Ra. Hamilton, ASSESSMENT OF FACTORS WHICH INFLUENCE PHARMD CLERKSHIP GRADES, American journal of pharmaceutical education, 61(2), 1997, pp. 157-160

Authors: BRICELAND LL TOBIN EH
Citation: Ll. Briceland et Eh. Tobin, FOCUS ON MEROPENEM - A BROAD-SPECTRUM PARENTERAL CARBAPENEM ANTIMICROBIAL AGENT, Formulary, 31(9), 1996, pp. 759

Authors: GRISWOLD MW LOMAESTRO BM BRICELAND LL
Citation: Mw. Griswold et al., QUINUPRISTIN-DALFOPRISTIN (RP-59500) - AN INJECTABLE STREPTOGRAMIN COMBINATION, American journal of health-system pharmacy, 53(17), 1996, pp. 2045-2053

Authors: GRISWOLD MW BRICELAND LL LESAR TS
Citation: Mw. Griswold et al., COSTS OF THERAPEUTIC ALTERNATIVES - PHYSICIANS KNOWLEDGE, The Annals of pharmacotherapy, 30(7-8), 1996, pp. 882-883

Authors: AMODIOGROTON M MADU A MADU CN BRICELAND LL SELIGMAN M MCMASTER P MILLER MH
Citation: M. Amodiogroton et al., SEQUENTIAL PARENTERAL AND ORAL CIPROFLOXACIN REGIMEN VERSUS PARENTERAL THERAPY FOR BACTEREMIA - A PHARMACOECONOMIC ANALYSIS, The Annals of pharmacotherapy, 30(6), 1996, pp. 596-602

Authors: LESAR TS BRICELAND LL
Citation: Ts. Lesar et Ll. Briceland, SURVEY OF ANTIBIOTIC CONTROL POLICIES IN UNIVERSITY-AFFILIATED TEACHING INSTITUTIONS, The Annals of pharmacotherapy, 30(1), 1996, pp. 31-34

Authors: PRESTON SL BRICELAND LL
Citation: Sl. Preston et Ll. Briceland, FLUCONAZOLE FOR ANTIFUNGAL PROPHYLAXIS IN CHEMOTHERAPY-INDUCED NEUTROPENIA, American journal of health-system pharmacy, 52(2), 1995, pp. 164-173

Authors: PRESTON SL BRICELAND LL LOMAESTRO BM LESAR TS BAILIE GR DRUSANO GL
Citation: Sl. Preston et al., DOSING ADJUSTMENT OF 10 ANTIMICROBIALS FOR PATIENTS WITH RENAL IMPAIRMENT, The Annals of pharmacotherapy, 29(12), 1995, pp. 1202-1207

Authors: BRICELAND LL CLEARY JD FLETCHER CV HEALY DP PELOQUIN CA
Citation: Ll. Briceland et al., RECENT ADVANCES - ANTIINFECTIVES, The Annals of pharmacotherapy, 29(10), 1995, pp. 1035-1040

Authors: PRESTON SL BRICELAND LL
Citation: Sl. Preston et Ll. Briceland, SINGLE DAILY DOSING OF AMINOGLYCOSIDES, Pharmacotherapy, 15(3), 1995, pp. 297-316

Authors: CIRA LM BRICELAND LL LESAR TS
Citation: Lm. Cira et al., PITFALLS OF USING ANTIMICROBIAL ORDER FORMS TO EVALUATE DRUG-USE, American journal of hospital pharmacy, 51(5), 1994, pp. 700-703

Authors: PRESTON SL BRICELAND LL LESAR TS
Citation: Sl. Preston et al., PENICILLIN ALLERGIES, American journal of hospital pharmacy, 51(15), 1994, pp. 1964-1964

Authors: PRESTON SL BRICELAND LL LESAR TS
Citation: Sl. Preston et al., ACCURACY OF PENICILLIN ALLERGY REPORTING, American journal of hospital pharmacy, 51(1), 1994, pp. 79-84

Authors: PRESTON SL BRICELAND LL
Citation: Sl. Preston et Ll. Briceland, INTRATHECAL ADMINISTRATION OF AMIKACIN FOR TREATMENT OF MENINGITIS SECONDARY TO CEPHALOSPORIN-RESISTANT ESCHERICHIA-COLI, The Annals of pharmacotherapy, 27(7-8), 1993, pp. 870-873

Authors: KANE MP BRICELAND LL HAMILTON RA
Citation: Mp. Kane et al., SOLVING DRUG-RELATED PROBLEMS IN THE PROFESSIONAL EXPERIENCE PROGRAM, American journal of pharmaceutical education, 57(4), 1993, pp. 347-351
Risultati: 1-17 |